PortfoliosLab logo
CURE vs. UTSL
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between CURE and UTSL is 0.39, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.0
Correlation: 0.4

Performance

CURE vs. UTSL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Direxion Daily Healthcare Bull 3x Shares (CURE) and Direxion Daily Utilities Bull 3X Shares (UTSL). The values are adjusted to include any dividend payments, if applicable.

50.00%100.00%150.00%200.00%250.00%NovemberDecember2025FebruaryMarchApril
156.61%
58.70%
CURE
UTSL

Key characteristics

Sharpe Ratio

CURE:

-0.44

UTSL:

0.86

Sortino Ratio

CURE:

-0.36

UTSL:

1.36

Omega Ratio

CURE:

0.95

UTSL:

1.18

Calmar Ratio

CURE:

-0.41

UTSL:

0.77

Martin Ratio

CURE:

-0.94

UTSL:

3.20

Ulcer Index

CURE:

19.78%

UTSL:

13.90%

Daily Std Dev

CURE:

42.74%

UTSL:

52.02%

Max Drawdown

CURE:

-69.19%

UTSL:

-79.55%

Current Drawdown

CURE:

-38.60%

UTSL:

-38.70%

Returns By Period

In the year-to-date period, CURE achieves a -5.19% return, which is significantly lower than UTSL's 3.67% return.


CURE

YTD

-5.19%

1M

-16.60%

6M

-25.94%

1Y

-16.39%

5Y*

9.31%

10Y*

9.72%

UTSL

YTD

3.67%

1M

-0.21%

6M

-14.45%

1Y

46.12%

5Y*

9.04%

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


CURE vs. UTSL - Expense Ratio Comparison

CURE has a 1.08% expense ratio, which is higher than UTSL's 0.99% expense ratio.


Expense ratio chart for CURE: current value is 1.08%, compared with the broader market range of 0.00% to 2.12%.0.50%1.00%1.50%2.00%
CURE: 1.08%
Expense ratio chart for UTSL: current value is 0.99%, compared with the broader market range of 0.00% to 2.12%.0.50%1.00%1.50%2.00%
UTSL: 0.99%

Risk-Adjusted Performance

CURE vs. UTSL — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CURE
The Risk-Adjusted Performance Rank of CURE is 66
Overall Rank
The Sharpe Ratio Rank of CURE is 66
Sharpe Ratio Rank
The Sortino Ratio Rank of CURE is 88
Sortino Ratio Rank
The Omega Ratio Rank of CURE is 88
Omega Ratio Rank
The Calmar Ratio Rank of CURE is 44
Calmar Ratio Rank
The Martin Ratio Rank of CURE is 77
Martin Ratio Rank

UTSL
The Risk-Adjusted Performance Rank of UTSL is 7777
Overall Rank
The Sharpe Ratio Rank of UTSL is 7777
Sharpe Ratio Rank
The Sortino Ratio Rank of UTSL is 7878
Sortino Ratio Rank
The Omega Ratio Rank of UTSL is 7676
Omega Ratio Rank
The Calmar Ratio Rank of UTSL is 7777
Calmar Ratio Rank
The Martin Ratio Rank of UTSL is 7575
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

CURE vs. UTSL - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Direxion Daily Healthcare Bull 3x Shares (CURE) and Direxion Daily Utilities Bull 3X Shares (UTSL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The chart of Sharpe ratio for CURE, currently valued at -0.44, compared to the broader market-1.000.001.002.003.004.00
CURE: -0.44
UTSL: 0.86
The chart of Sortino ratio for CURE, currently valued at -0.36, compared to the broader market-2.000.002.004.006.008.00
CURE: -0.36
UTSL: 1.36
The chart of Omega ratio for CURE, currently valued at 0.95, compared to the broader market0.501.001.502.002.50
CURE: 0.95
UTSL: 1.18
The chart of Calmar ratio for CURE, currently valued at -0.41, compared to the broader market0.002.004.006.008.0010.0012.00
CURE: -0.41
UTSL: 0.77
The chart of Martin ratio for CURE, currently valued at -0.94, compared to the broader market0.0020.0040.0060.00
CURE: -0.94
UTSL: 3.20

The current CURE Sharpe Ratio is -0.44, which is lower than the UTSL Sharpe Ratio of 0.86. The chart below compares the historical Sharpe Ratios of CURE and UTSL, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00NovemberDecember2025FebruaryMarchApril
-0.44
0.86
CURE
UTSL

Dividends

CURE vs. UTSL - Dividend Comparison

CURE's dividend yield for the trailing twelve months is around 1.22%, less than UTSL's 1.77% yield.


TTM20242023202220212020201920182017
CURE
Direxion Daily Healthcare Bull 3x Shares
1.22%1.17%2.02%0.38%0.02%0.17%0.40%0.70%0.18%
UTSL
Direxion Daily Utilities Bull 3X Shares
1.77%1.61%3.61%1.15%1.20%1.40%5.01%1.46%0.57%

Drawdowns

CURE vs. UTSL - Drawdown Comparison

The maximum CURE drawdown since its inception was -69.19%, smaller than the maximum UTSL drawdown of -79.55%. Use the drawdown chart below to compare losses from any high point for CURE and UTSL. For additional features, visit the drawdowns tool.


-50.00%-40.00%-30.00%-20.00%-10.00%NovemberDecember2025FebruaryMarchApril
-38.60%
-38.70%
CURE
UTSL

Volatility

CURE vs. UTSL - Volatility Comparison

Direxion Daily Healthcare Bull 3x Shares (CURE) and Direxion Daily Utilities Bull 3X Shares (UTSL) have volatilities of 27.89% and 26.83%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.


10.00%15.00%20.00%25.00%NovemberDecember2025FebruaryMarchApril
27.89%
26.83%
CURE
UTSL